Mary Prahl, MD

Assoc Prof of Clin Pediatrics
M_PEDS-INFECTIOUS DISEASE
--

Dr. Prahl is a clinician-scientist engaged in translational research evaluating human immune responses to infectious diseases during pregnancy and early childhood to facilitate the development of novel strategies for disease prevention.

Pregnancy and Early Childhood Malaria:
Dr. Prahl’s work is aimed at understanding the immunologic consequences of in utero malaria exposure and malaria prevention on the immune system during fetal development and early childhood. Current malaria vaccines have been limited by poor immunogenicity in young children living in malaria endemic areas, and further research is needed to determine the reasons for these poor immune responses to malaria antigens in order to develop new tools to fight the malaria epidemic. This research is based on collaborations with Makerere University/IDRC in Uganda. Dr. Prahl’s work is aimed at evaluating potential contributing mechanisms of immune tolerance resulting from in utero malaria exposure and evaluating the effect of malaria control measures on the developing immune responses. In addition to her translational immunology work, Dr. Prahl aims to encourage and train future medical providers in global health careers.

SARS-CoV-2 Infection and Vaccination in Pregnancy, Lactation, and Early Childhood:
Dr. Prahl’s work is aimed to address critical knowledge gaps in the immunologic impact of SARS-CoV-2 infection and vaccination during pregnancy, lactation, and early childhood. In addition, Dr. Prahl and her colleagues aim to determine mechanisms of transferred maternal-fetal immunity and the impact on protection against SARS-CoV-2 in early childhood.

Publications

Neutralizing antibody activity against SARS-CoV-2 variants in gestational age-matched mother-infant dyads after infection or vaccination.

JCI insight

Matsui Y, Li L, Prahl M, Cassidy AG, Ozarslan N, Golan Y, Gonzalez VJ, Lin CY, Jigmeddagva U, Chidboy MA, Montano M, Taha TY, Khalid MM, Sreekumar B, Hayashi JM, Chen PY, Kumar GR, Warrier L, Wu AH, Song D, Jegatheesan P, Rai DS, Govindaswami B, Needens JM, Rincon M, Myatt L, Asiodu IV, Flaherman VJ, Afshar Y, Jacoby VL, Murtha AP, Robinson JF, Ott M, Greene WC, Gaw SL

Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity.

Science translational medicine

Chakraborty S, Gonzalez JC, Sievers BL, Mallajosyula V, Chakraborty S, Dubey M, Ashraf U, Cheng BY, Kathale N, Tran KQT, Scallan C, Sinnott A, Cassidy A, Chen ST, Gelbart T, Gao F, Golan Y, Ji X, Kim-Schulze S, Prahl M, Gaw SL, Gnjatic S, Marron TU, Merad M, Arunachalam PS, Boyd SD, Davis MM, Holubar M, Khosla C, Maecker HT, Maldonado Y, Mellins ED, Nadeau KC, Pulendran B, Singh U, Subramanian A, Utz PJ, Sherwood R, Zhang S, Jagannathan P, Tan GS, Wang TT

Divergent early antibody responses define COVID-19 disease trajectories.

bioRxiv : the preprint server for biology

Chakraborty S, Gonzalez JC, Sievers BL, Mallajosyula V, Dubey M, Cheng BY, Tran KQT, Chakraborty S, Cassidy A, Chen ST, Sinnott A, Gelbart T, Golan Y, Prahl M, Singh U, Kim-Schulze S, Sherwood R, Zhang S, Marron TU, Gnjatic S, Gaw SL, Nadeau KC, Merad M, Jagannathan P, Tan GS, Wang TT

Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: Prospective cohort study.

medRxiv : the preprint server for health sciences

Song D, Prahl M, Gaw SL, Narasimhan S, Rai D, Huang A, Flores C, Lin CY, Jigmeddagva U, Wu AHB, Warrier L, Levan J, Nguyen CBT, Callaway P, Farrington L, Acevedo GR, Gonzalez VJ, Vaaben A, Nguyen P, Atmosfera E, Marleau C, Anderson C, Misra S, Stemmle M, Cortes M, McAuley J, Metz N, Patel R, Nudelman M, Abraham S, Byrne J, Jegatheesan P

Another spin.

Journal of hospital medicine

Prahl M, Dhaliwal G, Shulman ST, Doshi N, Monash B